Global Cord Blood Corp CO

NYS: CO | ISIN: KYG393421030   10/08/2023
1,280 USD (+5,79%)
(+5,79%)   10/08/2023

13 april 2023 · Global Cord Blood Corporation Announces Failure To File Interim Financials · Persbericht

16 augustus 2022 · Global Cord Blood Corporation Files Annual Report on Form 20-F · Persbericht

6 juli 2022 · Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM · Persbericht

5 juli 2022 · Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 · Persbericht

16 juni 2022 · Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis · Persbericht

16 juni 2022 · Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened · Persbericht

10 mei 2022 · Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition · Persbericht

29 april 2022 · Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights · Persbericht

28 februari 2022 · Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022 · Persbericht

23 februari 2022 · Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results · Persbericht

16 december 2021 · Global Cord Blood Corporation Announces Rejection of Alternate Ocean Proposal · Persbericht

7 december 2021 · Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting · Persbericht

24 november 2021 · Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2022 · Persbericht

17 november 2021 · Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2022 Financial Results · Persbericht

17 september 2021 · Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021 · Persbericht

30 augustus 2021 · Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2022 · Persbericht

25 augustus 2021 · Global Cord Blood Corporation to Report First Quarter Fiscal 2022 Financial Results · Persbericht

29 juli 2021 · Global Cord Blood Corporation Files Annual Report on Form 20-F · Persbericht

28 juni 2021 · Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2021 · Persbericht

22 juni 2021 · Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results · Persbericht

Mijn selecties